[Pe-030] English Poster Session 030

[Pe-030-2] Avalglucosidase alfa COMET Extension in Late-onset Pompe Disease: Efficacy and Safety At 97 Weeks

^○Mitsunobu Ikeda¹, Kishnani Priya S.², Diaz-Manera Jordi³, Chien Yin-Hsiu⁴, Choi Young Chul⁵, Dimachkie Mazen M.⁶, Schoser Benedikt⁷, COMET Investigator Group⁸ (1.Sanofi K.K., Japan, 2.Division of Medical Genetics, Department of Pediatrics, Duke University Medical Center, Durham, NC, USA, 3.John Walton Muscular Dystrophy Research Centre, Newcastle University International Centre for Life, Newcastle upon Tyne, UK, 4.Department of Medical Genetics and Pediatrics, National Taiwan University Hospital, Taipei, Taiwan, 5.Gangnam Severance Hospital, Yonsei University, College of Medicine, Seoul, Korea, 6.University of Kansas Medical Center, Department of Neurology, Kansas City, KS, USA, 7.Friedrich-Baur-Institute, Department of Neurology, LMU Klinikum Munchen, Munchen, Germany, 8.COMET Investigator Group)